Crossmark

The ABCDE approach to difficult weaning from venoarterial extracorporeal membrane oxygenation

Published Online: 2022-07-15

Published Print: 2022-12

Authors

Meuwese, Christiaan L.

Brodie, Daniel

Donker, Dirk W.
License Information

Text and Data Mining valid from 2022-07-15

Version of Record valid from 2022-07-15
More Information

Article History

Received: 10 June 2022

Accepted: 5 July 2022

First Online: 15 July 2022

Declarations

:

: Not applicable.

: CLM reports having received research funding from ‘Stichting Gezondheidszorg Spaarneland (SGS)’ foundation. DB receives research support from ALung Technologies. He has been on the medical advisory boards for Abiomed, Xenios, Medtronic, Inspira, and Cellenkos. He is the President-elect of the Extracorporeal Life Support Organization (ELSO) and the Chair of the Executive Committee of the International ECMO Network (ECMONet). DWD reports personal fees from Getinge-Maquet, Xenios NovaLung Fresenius, and Abiomed and research funding from ‘Stichting Gezondheidszorg Spaarneland (SGS)’ foundation, and consultancy and research cooperation with Getinge-Maquet.

Document is current